These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009 [TBL] [Abstract][Full Text] [Related]
4. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551 [TBL] [Abstract][Full Text] [Related]
6. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery. Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044 [TBL] [Abstract][Full Text] [Related]
8. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events. Dogan A; Icli A; Aksoy F; Varol E; Erdogan D; Ozaydin M; Kocyigit S Coron Artery Dis; 2012 Jan; 23(1):39-44. PubMed ID: 22107801 [TBL] [Abstract][Full Text] [Related]
9. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction. Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786 [TBL] [Abstract][Full Text] [Related]
10. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533 [TBL] [Abstract][Full Text] [Related]
11. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE; Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome. van Oijen MG; Claessen BE; Clappers N; van Schaik A; Laheij RJ; Jansen JB; Peters WH; Verheugt FW Am J Cardiol; 2008 Jul; 102(2):135-9. PubMed ID: 18602509 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease. Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641 [TBL] [Abstract][Full Text] [Related]
15. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort. Li N; Li S; Yu C; Gu S Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983 [TBL] [Abstract][Full Text] [Related]
16. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris. Gravning J; Ueland T; Mørkrid L; Endresen K; Aaberge L; Kjekshus J Scand Cardiovasc J; 2008 Jun; 42(3):214-21. PubMed ID: 18569954 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Emdin M; Passino C; Michelassi C; Titta F; L'abbate A; Donato L; Pompella A; Paolicchi A Eur Heart J; 2001 Oct; 22(19):1802-7. PubMed ID: 11549302 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome. Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634 [TBL] [Abstract][Full Text] [Related]
19. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H; Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Chalikias GK; Tziakas DN; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI Int J Cardiol; 2007 May; 117(3):333-9. PubMed ID: 16859776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]